Clinical Trial Update: Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid [Phase 1]

View source ↗

Summary

A Phase 1 single-dose study in healthy adults evaluating immediate-release and dispersible formulations of pretomanid to assess pharmacokinetics and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis

Drugs mentioned

• Pretomanid (pretomanid)

Snippet

Sponsor: Global Alliance for TB Drug Development | Conditions: Multi-drug Resistant Tuberculosis | Phase 1 | Status: COMPLETED | Results posted: 2024-07-24